Finance

Lists
175250:KOSDAQ
Icure Pharmaceutical Inc
â‚©1,755.00
-4.26%
(-78.00) 1D
Sep 14, 3:30:27 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 175250...
Open
â‚©1,831
High
â‚©1,831
Low
â‚©1,748
Mkt. cap
108.35B
Avg. vol.
269.76K
Volume
130.44K
52-wk high
â‚©3,300
52-wk low
â‚©1,661
EPS
-â‚©539
Shares outstanding
61.74M
No. of employees
232
Open
â‚©1,831
High
â‚©1,831
Low
â‚©1,748
Mkt. cap
108.35B
Avg. vol.
269.76K
Volume
130.44K
52-wk high
â‚©3,300
52-wk low
â‚©1,661
EPS
-â‚©539
Shares outstanding
61.74M
No. of employees
232
About Icure Pharmaceutical Inc
CEOChoi Young-Kweon
Employees232
Founded2000
Headquarters-
SectorPersonal care products
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
25.14B
-
32.19B
37.65B
Cost of goods sold
24.10B
-
28.71B
32.29B
Cost of revenue
24.10B
-
28.71B
32.29B
Research and development expenses
770.41M
-
799.85M
812.87M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.44B
-
2.17B
1.72B
Operating expense
4.14B
-
3.28B
2.79B
Total operating expenses
28.24B
-
31.98B
35.08B
Operating income
-3.11B
-
207.55M
2.57B
Other non operating income
24.37M
-
-311.21M
52.07M
EBT including unusual items
-3.87B
-
-668.69M
2.26B
EBT excluding unusual items
-3.89B
-
-487.35M
2.32B
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
108.62M
-
64.93M
63.09M
Net income
-3.70B
-
-555.93M
2.32B
Net profit margin
-14.73%
-
-1.73%
6.15%
Earnings per share
-
-
-
-
Interest and investment income
67.58M
-
68.98M
45.46M
Interest expense
-893.38M
-
-449.50M
-377.12M
Net interest expenses
-825.80M
-
-380.52M
-331.65M
Depreciation and amortization charges
441.71M
-
302.90M
171.26M
EBITDA
-1.35B
-
1.11B
3.37B
Gain or loss from assets sale
-15.34M
-
27.32M
-130.10M
AI content may include mistakes. Learn more
Google apps